Upstream Bio (UPB) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to -$0.63.
- Upstream Bio's EPS (Weighted Average and Diluted) rose 9094.83% to -$0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.69, marking a year-over-year increase of 14609.75%. This contributed to the annual value of -$5.58 for FY2024, which is 5688.43% up from last year.
- Upstream Bio's EPS (Weighted Average and Diluted) amounted to -$0.63 in Q3 2025, which was up 9094.83% from -$0.74 recorded in Q2 2025.
- Upstream Bio's 5-year EPS (Weighted Average and Diluted) high stood at -$0.51 for Q1 2025, and its period low was -$6.96 during Q3 2024.
- For the 3-year period, Upstream Bio's EPS (Weighted Average and Diluted) averaged around -$3.2, with its median value being -$2.11 (2023).
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 22985.78% in 2024, then soared by 9094.83% in 2025.
- Upstream Bio's EPS (Weighted Average and Diluted) (Quarter) stood at -$5.05 in 2023, then surged by 68.46% to -$1.59 in 2024, then skyrocketed by 60.44% to -$0.63 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.63 for Q3 2025, versus -$0.74 for Q2 2025 and -$0.51 for Q1 2025.